Research Paper Volume 15, Issue 16 pp 7956—7973
A novel telomere-related gene prognostic signature for survival and drug treatment efficiency prediction in lung adenocarcinoma
Figure 7. Immune subtypes of the TRGs risk group. (A) Percentage of the six immune subtypes in the high and low TRGs risk groups. (B) and (C) Correlation of the TIDE score with TRG risk score. (D) and (E) Correlation of the exclusion score with TRG risk score.